DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

370.35 0.45 (0.12%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

IBB $370.35 0.12%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $372.10
Previous Close $369.90
Daily Range $368.06 - $372.10
52-Week Range $242.36 - $385.02
Market Cap $9.0B
P/E Ratio -1,610.22
Dividend (Yield) $0.23 (0.0%)
Ex-Dividend Date
Dividend Pay Date
Volume 840,802
Average Daily Volume 1,576,623
Current FY EPS $0.00




Financial Services

iShares NASDAQ Biotechnology Index (ETF) (IBB) Description

The investment seeks investment results that correspond generally to the price and yield performance before fees and expenses of the NASDAQ Biotechnology Index (the underlying index). Website:

News & Commentary

What Is Carl Icahn's Net Worth?

A look at the billionaire activist investor and hedge-fund manager, including some cautionary tales.

IBB, CELG, AMGN, REGN: Large Inflows Detected at ETF

Gilead Sciences- A Rare Undervalued Company In A Frothy Biotech Market

Deforestation Impacting Pharmaceutical Industry

The Pharma Pipeline: Exploring An Underestimated Investment Theme

Analyst: Greek Crisis An 'Opportunity' To Buy Europe, Biotech & SMID-Cap Discretionary

Biotech Weekly: Top Value Biotech Picks Starting Q3 2015

Biotech Stocks: 2 to Avoid, 1 to Buy

Arrowhead Research Corp. and Galena Biopharma are two speculative biotech stocks that investors may want to avoid, while top dog Celgene Corp. still looks like a great pick up. Here's why.

Vertex Pharma: Well Positioned To Set New Highs

Jim Cramer -- Micron, Other PC-Tied Chip Stocks Continue to Struggle

See More IBB News...

IBB's Top Competitors

IBB $370.35 (0.12%)
Current stock: IBB
VTA $11.76 (0.68%)
Current stock: VTA
NCV $8.37 (0.72%)
Current stock: NCV
ZTR $12.95 (0.15%)
Current stock: ZTR